Healthcare Services
10 recent notes from companies in this sector. 0 companies tracked.
Deep Health AI puts ₹2.85 cr into land for wellness centre, discloses late
The advance payment equals 9.5% of the ₹30 cr market cap. Disclosure came months late due to an 'oversight'.
QMS Medical cuts service-margin outlook to 25% from over 50%
A cost-accounting rethink forces a sharp downgrade in profitability guidance for the company's high-growth service segment.
Dr Lalchandani Labs survives on a one-time settlement. Auditors qualify the accounts.
A ₹61.08 lacs one-time settlement gain is the only thing standing between the company and an operational loss. Auditors flagged NPA classification and unpaid statutory dues.
Jeena Sikho kills Entero deal, guides ₹300 cr profit for FY27
The health-care chain walked away from a distribution partnership covering one lakh pharmacies after the partner demanded extra money. FY26 profit jumped 177% to ₹222 crore.
Nephrocare Health Services transcript adds no new material data
The Q4 and FY26 earnings call transcript confirms previously disclosed financial results and strategic outlooks.
Suraksha Diagnostic transcript confirms previously issued FY27 guidance
The Q4 and FY26 earnings transcript adds no new material information to the company's previously disclosed financial results and outlook.
Krsnaa Diagnostics posts FY26 profit of ₹102.7 cr but the numbers are stale
The audited results disclose no new information beyond what the exchange already has. A ₹62.7 crore tax demand remains unresolved.
Krsnaa's profit is up 24% but it's hiding a ₹63 crore tax demand.
Standalone net profit rose to ₹102.7 crore, but ₹25.9 crore of that was a one-off investment revaluation. Auditors also flagged a ₹62.7 crore tax claim.
Max Healthcare delays Gurgaon hospital, cuts oncology revenue outlook
Management now expects the 500-bed Gurgaon facility by end-FY27, not H1. Oncology's share of revenue is seen stabilising at 21-22%, down from a prior 25-26%.
Suraksha Diagnostic revenue lifts 21% as margins tighten
FY26 revenue climbs to ₹300.68 cr while profit growth stalls at 1.9%. The board initiates a ₹0.50 dividend.